N Binkley, D Gemar, J Engelke… - Journal of Clinical …, 2011 - Endocrine Soc Address all correspondence and requests for reprints to: Neil Binkley, MD, University of Wisconsin Osteoporosis Research Program, 2870 University Avenue, Suite 100, Madison, Wisconsin 53705. E-mail: nbinkley{at}wisc.edu. ... Context:Whether ergocalciferol (D 2 ) and ... Cited by 4 - Related articles - All 3 versions
CP Kovesdy, JL Lu, SM Malakauskas… - American Journal of …, 2011 - Elsevier The efficacy of 25-hydroxyvitamin D (25[OH]D) supplementation versus vitamin D receptor activators for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) stages 3 or 4 and vitamin D deficiency is unclear. ... 80 patients with CKD stages ...
L Brard, TS Lange, K Robison, KK Kim, T Ara… - Gynecologic …, 2011 - Elsevier We modified the Ergocalciferol structure to generate MT19c, a heterocyclic vitamin-D derivative. Hypercalcemic liabilities of MT19c were assessed by estimating the blood calcium levels in drug treated animals. VDR agonistic or antagonistic properties of MT19c were ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
